China’s Tongling Jieya Biotechnology is planning to develop a factory that will produce disposable sanitary products in Egypt, according to a stock market filing.

As part of the plan to develop and operate the facility, the company is establishing a subsidiary in the North African country.

The total investment in the project is estimated to be approximately RMB467,101,200 ($68.5m).

In its statement, Tongling Jieya Biotechnology said that it would “implement the investment in stages based on market demand and business progress, adjusting the investment amount and method as needed, and fulfilling the corresponding review procedures and information disclosure obligations”.

The facility is expected to produce up to 10 billion wet wipes a year, as well as 2 billion baby diapers and 100,000 tonnes of nonwoven fabrics.

This is expected to generate about $270m in annual revenue and employ around 1,000 people when the facility is operating at full capacity.

The plan to establish the subsidiary and develop the factory was approved at a company board meeting on 8 April 2026.

In its statement, the company said: “The management was authorised to handle the signing of agreements and documents related to this investment and construction, and to apply for administrative permits or filings with the relevant authorities such as the Ministry of Commerce and the State Administration of Foreign Exchange.”

The construction and implementation of the project still requires approval from Egyptian government departments.

Under current plans, the factory will be developed in the China-Egypt TEDA Suez Economic and Trade Cooperation Zone, located within the wider Suez Canal Economic Zone (SC Zone).

The land for the project has already been purchased, covering an area of 160,000 square metres.

The scope of the project will include developing:

• 14 production lines
• Quality control facilities
• Auxiliary equipment

The statement from Tongling Jieya Biotechnology estimates a two-year construction period for the project.

The contract for the land on which the project will be built was signed with TEDA Special Economic Zone Development Company on 23 December 2025, with a value of $8,465,400.

Tongling Jieya Biotechnology said the planned facility in Egypt is important for the company’s “globalisation strategy”.

It said: “Egypt is located at the crossroads of Asia, Africa and Europe, with a superior geographical location, and has signed a number of free trade agreements with major European and American markets, which is conducive to the company’s further expansion and coverage of global markets outside the United States.”

Established in 2008, the China-Egypt TEDA Suez Economic and Trade Cooperation Zone has become one of the SCZone’s most prominent industrial hubs.

By July last year, it had attracted 185 companies and over $3bn in cumulative investment.

The land deal for this project was one of three agreements announced in December last year relating to the zone, with a total value of more than a billion dollars.

At the time, SC Zone chairman Walid Gamal El-Din said that the largest was a project led by the Chinese chemical fibre specialist Xin Feng Ming.

This will involve the construction of an integrated polyester fiber and polymer complex with investments exceeding $800m.The facility is expected to be built over about 400,000 square meters and developed in three phases, with a combined annual production capacity of 1.08 million tonnes. It is expected to create around 3,000 jobs.

A second project with Chaoyang Langma will establish a $190m tyre manufacturing complex producing heavy-duty truck and passenger car tyres. The facility will span 200,000 square meters and employ about 1,400 workers.